Elevated extracellular [K+] inhibits death-receptor- and chemical-mediated apoptosis prior to caspase activation and cytochrome c release

Biochem J. 2001 Jul 1;357(Pt 1):137-45. doi: 10.1042/0264-6021:3570137.

Abstract

Efflux of intracellular K(+) and cell shrinkage are features of apoptosis in many experimental systems, and a regulatory role has been proposed for cytoplasmic [K(+)] in initiating apoptosis. We have investigated this in both death-receptor-mediated and chemical-induced apoptosis. Using Jurkat T cells pre-loaded with the K(+) ion surrogate (86)Rb(+), we have demonstrated an efflux of intracellular K(+) during apoptosis that was concomitant with, but did not precede, other apoptotic changes, including phosphatidylserine externalization, mitochondrial depolarization and cell shrinkage. To further clarify the role of K(+) ions in apoptosis, cytoprotection by elevated extracellular [K(+)] was studied. Induction of apoptosis by diverse death-receptor and chemical stimuli in two cell lines was inhibited prior to phosphatidylserine externalization, mitochondrial depolarization, cytochrome c release and caspase activation. Using a cell-free system, we have demonstrated a novel mechanism by which increasing [K(+)] inhibited caspase activation. In control dATP-activated lysates, Apaf-1 oligomerized to a biologically active caspase processing approximately 700 kDa complex and an inactive approximately 1.4 MDa complex. Increasing [K(+)] inhibited caspase activation by preventing formation of the approximately 700 kDa complex, but not of the inactive complex. Thus intracellular and extracellular [K(+)] markedly affect caspase activation and the initiation of apoptosis induced by both death-receptor ligation and chemical stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Antibodies / pharmacology
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Caspase Inhibitors
  • Caspases / metabolism*
  • Cysteine Proteinase Inhibitors / pharmacology
  • Cytochrome c Group / metabolism*
  • Cytosol / physiology
  • Enzyme Activation
  • Etoposide / pharmacology
  • Extracellular Space / physiology
  • Flow Cytometry
  • Humans
  • Intracellular Membranes / drug effects
  • Intracellular Membranes / physiology
  • Jurkat Cells
  • Kinetics
  • Membrane Potentials / physiology
  • Mitochondria / drug effects
  • Mitochondria / physiology
  • Phosphatidylserines / metabolism
  • Potassium / pharmacology*
  • Potassium Chloride / pharmacology
  • Receptors, Tumor Necrosis Factor / drug effects
  • Receptors, Tumor Necrosis Factor / physiology*
  • Rubidium / pharmacokinetics
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / physiology*
  • Tumor Cells, Cultured
  • fas Receptor / drug effects
  • fas Receptor / physiology

Substances

  • Amino Acid Chloromethyl Ketones
  • Antibodies
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Cytochrome c Group
  • Phosphatidylserines
  • Receptors, Tumor Necrosis Factor
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • fas Receptor
  • Potassium Chloride
  • Etoposide
  • Caspases
  • Rubidium
  • Potassium